Foghorn Therapeutics Inc. (FHTX)
5.21
+0.05 (0.97%)
Upcoming Events
Latest Headlines
Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director
July 1, 2026 7:00 AM - StreetInsider
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Lynch Thomas J. Jr.
June 25, 2026 4:07 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Duty Stuart
June 25, 2026 4:06 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Biller Scott
June 25, 2026 4:05 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Gallagher Neil
June 25, 2026 4:04 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Mendelsohn Michael
June 25, 2026 4:04 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: SMITH IAN F
June 25, 2026 4:03 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: GILL SIMBA
June 25, 2026 4:02 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: PARSHALL B LYNNE
June 25, 2026 4:01 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Cole Douglas G.
June 25, 2026 4:01 PM - SEC Filing
Form 8-K Foghorn Therapeutics For: Jun 24
June 24, 2026 4:01 PM - SEC Filing
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
June 22, 2026 8:30 AM - StreetInsider
Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK
June 10, 2026 5:19 AM - StreetInsider
Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
June 5, 2026 7:00 AM - StreetInsider
Form SCHEDULE 13G/A Foghorn Therapeutics Filed by: BIOTECHNOLOGY VALUE FUND L P
May 15, 2026 4:16 PM - SEC Filing
Form SCHEDULE 13G/A Foghorn Therapeutics Filed by: Flynn James E
May 14, 2026 6:21 PM - SEC Filing
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May
May 12, 2026 7:00 AM - Globe NewsWire
Foghorn Therapeutics Inc. (FHTX) Misses Q1 EPS by 1c
May 7, 2026 7:44 AM - StreetInsider
Form 10-Q Foghorn Therapeutics For: Mar 31
May 7, 2026 7:03 AM - SEC Filing
Form 8-K Foghorn Therapeutics For: May 07
May 7, 2026 7:02 AM - SEC Filing
Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update
May 7, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G/A Foghorn Therapeutics Filed by: FMR LLC
May 6, 2026 11:19 AM - SEC Filing
Form ARS Foghorn Therapeutics For: Dec 31
April 30, 2026 7:10 AM - SEC Filing
Form DEFA14A Foghorn Therapeutics
April 30, 2026 7:05 AM - SEC Filing
Form DEF 14A Foghorn Therapeutics For: Jun 24
April 30, 2026 7:01 AM - SEC Filing
Foghorn Therapeutics (FHTX) Reiterated at Buy by Stifel After AACR'26 Presentation
April 27, 2026 7:31 AM - StreetInsider
Full Article List
